SPONSOR
Xuanwu Hospital, Beijing
Total Trials
11
Recruiting
11
Phases
Phase 3, Phase 4
Conditions studied: Alzheimer DiseaseStroke, IschemicStroke, AcuteThrombosis, BrainDrug EffectIdiopathic Inflammatory Demyelinating Disorders of the Central Nervous SystemChronic InsomniaAcute Insomnia DisorderAcute Ischemic StrokeBasilar Artery Occlusion
Xuanwu Hospital, Beijing is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Alzheimer Disease, Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Xuanwu Hospital, Beijing
How many clinical trials has Xuanwu Hospital, Beijing sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Xuanwu Hospital, Beijing, of which 11 are actively recruiting participants. These trials cover conditions including Alzheimer Disease, Stroke, Ischemic, Stroke, Acute. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Xuanwu Hospital, Beijing research focus on?
Xuanwu Hospital, Beijing clinical trials span Alzheimer Disease, Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect, and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Xuanwu Hospital, Beijing clinical trial?
To participate in a Xuanwu Hospital, Beijing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Xuanwu Hospital, Beijing trials with current recruitment status updated daily.
Clinical Trials by Xuanwu Hospital, Beijing
NCT05995418
Recruiting
Study on the Health Economic Burden of Alzheimer's Disease in China
Alzheimer Disease
NCT06658197 Phase 3
Recruiting
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
Stroke, Ischemic
NCT06942611
Recruiting
Transcranial Electrical Stimulation for Treating Chronic Pain in Inflammatory Demyelinating Diseases
Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System
NCT06658184
Recruiting
Effects of Sleep Restriction and Stimulus Control in Chronic Insomnia Patients
Chronic Insomnia
NCT06967922
Recruiting
Impact of Analytic-integrative Cognitive Behavioural Therapy on Acute Insomnia Disorder (Stress)
Acute Insomnia Disorder
NCT07203625 Phase 4
Recruiting
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
Acute Ischemic Stroke
NCT07419997
Recruiting
A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke
Stroke
NCT05899582
Recruiting
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
Symptomatic Chronic Middle Cerebral Artery Occlusion
NCT07057973
Recruiting
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Ferric Carboxymaltose
NCT06969040
Recruiting
The Effect of Standard Cognitive-behavioral Therapy+Transcranial Alternating Current on Refractory Insomnia Disorder
Insomnia
NCT07396051
Recruiting
Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)
Adjacent Segment Degeneration
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology